Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation

Neuroscience

Volumn 144, Issue 4, 2007, Pages 1516-1522

  Marchalant, Y ^a,c   Rosi, S ^a,b   Wenk, G L ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

activated microglia; Alzheimer's disease; cannabinoid receptors; inflammation; LPS; spatial memory

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; DIMETHYL SULFOXIDE; ENDOCANNABINOID; LIPOPOLYSACCHARIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BRAIN FOURTH VENTRICLE; CELL ACTIVATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; ENCEPHALITIS; EXPERIMENTAL TEST; MALE; MAZE TEST; MEMORY DISORDER; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZOXAZINES; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ENDOCANNABINOIDS; GLIOSIS; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; MALE; MAZE LEARNING; MEMORY DISORDERS; MICROGLIA; MORPHOLINES; NAPHTHALENES; RATS; RATS, INBRED F344; RECEPTOR, CANNABINOID, CB1; RECEPTORS, CANNABINOID; TREATMENT OUTCOME;

EID: 33846335526     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.11.016     Document Type: Article

References (33)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B., Finch C.E., Frautschy S., Griffin W.S.T., Hampel H., Landreth G., McGeer P.L., Mrak R., MacKenzie I., O'Banion K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray A. Inflammation in Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
2. Begg M., Pacher P., Batkai S., Osei-Hyiaman D., Offertaler L., Mo F.M., Liu J., and Kunos G. Evidence for novel cannabinoid receptors. Pharmacol Ther 2 (2005) 133-145
3. Benito C., Nunez E., Tolon R.M., Carrier E.J., Rabano A., Hillard C.J., and Romero J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci 23 (2003) 11136-11141
4. Bernardino L., Xapelli S., Silva A.P., Jakobsen B., Poulsen F.R., Oliveira C.R., Vezzani A., Malva J.O., and Zimmer J. Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J Neurosci 25 (2005) 6734-6744
5. Castellano C., Rossi-Arnaud C., Cestari V., and Costanzi M. Cannabinoids and memory: animal studies. Curr Drug Targets CNS Neurol Disord 2 (2003) 389-402
6. Facchinetti F., Del Giudice E., Furegato S., Passarotto M., and Leon A. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lipopolysaccharide. Glia 41 (2003) 161-168
7. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., and Uhl G.R. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071 (2006) 10-23
8. Hampson A.J., and Grimaldi M. Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity. Eur J Neurosci 13 (2001) 1529-1536
9. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., and Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res 780 (1998) 294-303
10. Hauss-Wegrzyniak B., Vraniak P., and Wenk G.L. The effects of a novel NSAID upon chronic neuroinflammation are age dependent. Neurobiol Aging 20 (1999) 305-313
11. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., and Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19 11 (1999) 4544-4558
12. Kim S.U., and de Vellis J. Microglia in health and disease. J Neurosci Res 81 (2005) 302-313
13. Klein T.W., Newton C., Larsen K., Lu L., Perkins I., Nong L., and Friedman H. The cannabinoid system and immune modulation. J Leukoc Biol 74 (2003) 486-496
14. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5 (2005) 400-411
15. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutiérrez S.O., van de Stelt M., López-Rodriguez M.L., Casanova E., Schu{combining double acute accent}tz G., Zieglgänsberger W., Di Marzo V., Behl C., and Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
16. Minghetti L., and Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 54 (1998) 99-125
17. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
18. Nadel L., and Land C. Memory traces revisited. Nat Rev Neurosci 1 (2000) 209-212
19. Neumann H. Control of glial immune function by neurons. Glia 36 (2001) 191-199
20. Onaivi E.S., Ishigurao H., Gong J., Patel S., Perchuk A., Meozzi P., Myers L., Mora Z., Tagliaferro P., Gardner E., Brusco A., Akinshola B.E., Liu Q., Hope B., Iwasaki S., Arinami T., Teasenfitz L., and Uhl G.R. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N YAcad Sci 1074 (2006) 514-536
21. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4 (2003) 873-884
22. Ramirez B.G., Blazquez C., Gomez del Pulgar T., Guzman M., and de Ceballos M.L. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25 (2005) 1904-1913
23. Rosi S., Ramirez-Amaya V., Hauss-Wegrzyniak B., and Wenk G.L. Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptors. J Neuroinflammation 1 (2004) 12
24. Rosi S., Ramirez-Amaya V., Vazdarjanova A., Worley P.F., Barnes C.A., and Wenk G.L. Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression. J Neurosci 25 (2005) 723-731
25. Sheng W.S., Hu S., Min X., Cabral G.A., Lokensgard J.R., and Peterson P.K. Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes. Glia 49 (2005) 211-219
26. Stella N. Cannabinoid signaling in glial cells. Glia 48 (2004) 267-277
27. Streit W.J. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 77 (2004) 1-8
28. Takahashi K.A., and Castillo P.E. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 139 (2006) 795-802
29. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
30. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., Marnett L.J., Di Marzo V., Pittman Q.J., Patel K.D., and Sharkey K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310 (2005) 329-332
31. Waksman Y., Olson J., Carlisle S.J., and Cabral G.A. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J Pharmacol Exp Ther 288 (1999) 1357-1366
32. Walter L., Franklin A., Witting A., Moller T., and Stella N. Astrocytes in culture produce anandamide and other acylethanolamides. J Biol Chem 277 (2002) 20869-20876
33. Wenk G.L., Parson C., and Danysz W. Potential role of NMDA receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine. Behav Pharmacol 17 (2006) 411-412